ReviewAging and disease2024

Polypharmacological Potential of Phosphodiesterase 5 Inhibitors for the Treatment of Neurocognitive Disorders.

Ashish Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.